Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part III: Implementations for the Diagnosis of Non-Cancerous Disorders, Both Oral and Systemic.
1H NMR analysis
NMR-based metabolomics
acute sore throat conditions (pharyngitis)
chemical pathology
dental caries
diagnosis
metabolomics
oral diseases
periodontal diseases
prognostic monitoring
saliva
systemic diseases
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
01 Jan 2023
01 Jan 2023
Historique:
received:
20
11
2022
revised:
27
12
2022
accepted:
28
12
2022
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
This communication represents Part III of our series of reports based on the applications of human saliva as a useful and conveniently collectable medium for the discovery, identification and monitoring of biomarkers, which are of some merit for the diagnosis of human diseases. Such biomarkers, or others reflecting the dysfunction of specific disease-associated metabolic pathways, may also be employed for the prognostic pathological tracking of these diseases. Part I of this series set the experimental and logistical groundwork for this report, and the preceding paper, Part II, featured the applications of newly developed metabolomics technologies to the diagnosis and severity grading of human cancer conditions, both oral and systemic. Clearly, there are many benefits, both scientific and economic, associated with the donation of human saliva samples (usually as whole mouth saliva) from humans consenting to and participating in investigations focused on the discovery of biomolecular markers of diseases. These include usually non-invasive collection protocols, relatively low cost when compared against blood sample collection, and no requirement for clinical supervision during collection episodes. This paper is centred on the employment and value of 'state-of-the-art' metabolomics technologies to the diagnosis and prognosis of a wide range of non-cancerous human diseases. Firstly, these include common oral diseases such as periodontal diseases (from type 1 (gingivitis) to type 4 (advanced periodontitis)), and dental caries. Secondly, a wide range of extra-oral (systemic) conditions are covered, most notably diabetes types 1 and 2, cardiovascular and neurological diseases, and Sjögren's syndrome, along with a series of viral infections, e.g., pharyngitis, influenza, HIV and COVID-19. Since the authors' major research interests lie in the area of the principles and applications of NMR-linked metabolomics techniques, many, but not all, of the studies reviewed were conducted using these technologies, with special attention being given to recommended protocols for their operation and management, for example, satisfactory experimental model designs; sample collection and laboratory processing techniques; the selection of sample-specific NMR pulse sequences for saliva analysis; and strategies available for the confirmation of resonance assignments for both endogenous and exogenous molecules in this biofluid. This article also features an original case study, which is focussed on the use of NMR-based salivary metabolomics techniques to provide some key biomarkers for the diagnosis of pharyngitis, and an example of how to 'police' such studies and to recognise participants who perceive that they actually have this disorder but do not from their metabolic profiles and multivariate analysis pattern-based clusterings. The biochemical and clinical significance of these multidimensional metabolomics investigations are discussed in detail.
Identifiants
pubmed: 36676991
pii: metabo13010066
doi: 10.3390/metabo13010066
pmc: PMC9864626
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Periodontol 2000. 2016 Feb;70(1):53-64
pubmed: 26662482
Rheumatol Int. 2015 May;35(5):829-36
pubmed: 25327574
Metabolites. 2020 Dec 19;10(12):
pubmed: 33352779
Nestle Nutr Inst Workshop Ser. 2016;84:103-10
pubmed: 26764479
J Dent Res. 2020 Jul;99(8):989
pubmed: 32271653
Physiol Behav. 2007 Nov 23;92(4):583-90
pubmed: 17572453
Annu Rev Virol. 2021 Sep 29;8(1):373-391
pubmed: 34586876
Anal Chem. 2006 Jul 1;78(13):4281-90
pubmed: 16808434
Magn Reson Chem. 2022 Dec;60(12):1097-1112
pubmed: 34847251
Clin Infect Dis. 2002 Jul 15;35(2):113-25
pubmed: 12087516
J Oral Pathol Med. 2002 Aug;31(7):421-31
pubmed: 12165061
Metabolites. 2020 Aug 06;10(8):
pubmed: 32781584
Biomed Res Int. 2014;2014:962903
pubmed: 25276835
J Oral Sci. 2003 Jun;45(2):85-91
pubmed: 12930131
J Oral Microbiol. 2015 Sep 18;7:29129
pubmed: 26387647
Methods Mol Biol. 2010;666:21-30
pubmed: 20717775
J Dent Res. 1991 Mar;70(3):182-6
pubmed: 1999556
Periodontol 2000. 2021 Feb;85(1):46-81
pubmed: 33226703
J Immunother Cancer. 2018 May 14;6(1):35
pubmed: 29754585
Sensors (Basel). 2022 Feb 18;22(4):
pubmed: 35214519
Thorac Cancer. 2022 Feb;13(3):460-465
pubmed: 34918488
PLoS One. 2017 Aug 24;12(8):e0182767
pubmed: 28837579
Mol Biosyst. 2016 Jul 19;12(8):2562-71
pubmed: 27265744
Crit Rev Oncol Hematol. 2017 Feb;110:62-73
pubmed: 28109406
Annu Rev Nutr. 2006;26:229-50
pubmed: 16848706
J Oral Sci. 2020 Dec 23;63(1):22-26
pubmed: 33116006
Infect Immun. 1977 Jul;17(1):55-61
pubmed: 407163
J Periodontol. 2018 Jun;89 Suppl 1:S9-S16
pubmed: 29926938
Analyst. 2016 Jan 7;141(1):236-42
pubmed: 26580299
J Oral Microbiol. 2021 Mar 25;13(1):1902707
pubmed: 33828820
Metabolites. 2022 Aug 24;12(9):
pubmed: 36144183
Sci Rep. 2022 Jan 13;12(1):689
pubmed: 35027617
PLoS One. 2014 Nov 05;9(11):e112373
pubmed: 25372853
NMR Biomed. 1999 Oct;12(6):345-56
pubmed: 10516616
PLoS One. 2013 May 16;8(5):e64298
pubmed: 23696880
Clin Ther. 2015 Mar 1;37(3):498-504
pubmed: 25732629
Anal Chem. 2020 Dec 15;92(24):15688-15692
pubmed: 33215503
J Sep Sci. 2021 Oct;44(19):3677-3690
pubmed: 34350708
Elife. 2019 Feb 12;8:
pubmed: 30747106
Molecules. 2020 Jul 07;25(13):
pubmed: 32646009
J Neurochem. 1984 Dec;43(6):1631-4
pubmed: 6436440
Sci Rep. 2014 Nov 14;4:7046
pubmed: 25395095
FEBS J. 2021 Nov;288(22):6392-6405
pubmed: 33370493
Nat Commun. 2019 Dec 20;10(1):5813
pubmed: 31862950
J Proteome Res. 2016 Aug 5;15(8):2491-9
pubmed: 27306956
J Dent Res. 2015 Dec;94(12):1628-37
pubmed: 26377570
Nat Rev Clin Oncol. 2011 Mar;8(3):171-6
pubmed: 21364690
Front Microbiol. 2020 Nov 30;11:573196
pubmed: 33329431
Mol Pharmacol. 2016 Mar;89(3):388-98
pubmed: 26719580
Methods Mol Biol. 2021;2210:167-172
pubmed: 32815137
Neurol Sci. 2020 May;41(5):1201-1210
pubmed: 31897951
Clin Transl Immunology. 2016 May 13;5(5):e82
pubmed: 27350881
J Proteome Res. 2018 Apr 6;17(4):1521-1531
pubmed: 29498859
Clin Lab Sci. 1994 Jan-Feb;7(1):39-44
pubmed: 10172036
J Clin Med. 2020 Feb 08;9(2):
pubmed: 32046271
Sleep Breath. 2022 Dec;26(4):1857-1868
pubmed: 35122603
Metabolomics. 2021 Jan 1;17(1):1
pubmed: 33387070
Gut Microbes. 2016 May 3;7(3):189-200
pubmed: 26963409
Int J Oral Sci. 2016 Sep 29;8(3):133-7
pubmed: 27585820
Oral Dis. 2019 Sep;25(6):1545-1554
pubmed: 31077633
In Vivo. 2019 Jul-Aug;33(4):1165-1174
pubmed: 31280206
Appl Environ Microbiol. 1977 Aug;34(2):164-9
pubmed: 303077
Atherosclerosis. 2014 Nov;237(1):123-8
pubmed: 25238219
ACS Appl Mater Interfaces. 2014 Sep 10;6(17):14772-8
pubmed: 25158299
Molecules. 2021 Jul 06;26(14):
pubmed: 34299389
BMJ. 2018 Jun 13;361:k2179
pubmed: 29899036
J Nutr. 2017 May;147(5):727-745
pubmed: 28356427
J Periodontol. 2012 May;83(5):635-43
pubmed: 21861638
Analyst. 2017 Oct 7;142(19):3715-3724
pubmed: 28871304
Aust Dent J. 2009 Sep;54 Suppl 1:S11-26
pubmed: 19737262
Jpn Dent Sci Rev. 2021 Nov;57:224-230
pubmed: 34760030
Caries Res. 1981;15(5):377-85
pubmed: 6942921
Curr Opin Gastroenterol. 2014 May;30(3):332-8
pubmed: 24625896
Metabolites. 2021 Sep 03;11(9):
pubmed: 34564411
Cell Mol Biol Lett. 2020 Mar 5;25:15
pubmed: 32161622
J Gen Microbiol. 1977 Mar;99(1):139-55
pubmed: 405455
J Alzheimers Dis. 2017;58(2):355-359
pubmed: 28453477
ScientificWorldJournal. 2019 Nov 16;2019:3162063
pubmed: 31827413
Metabolites. 2020 Jan 26;10(2):
pubmed: 31991929
Genet Med. 2009 Jan;11(1):3-14
pubmed: 18813139
J Biomed Opt. 2012 Mar;17(3):037003
pubmed: 22502575
J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8
pubmed: 18840817
Nat Rev Microbiol. 2014 Oct;12(10):661-72
pubmed: 25198138
J Oral Microbiol. 2019 Jun 04;11(1):1617014
pubmed: 34109015
Bioinformatics. 2004 Jan 1;20(1):93-9
pubmed: 14693814
Environ Microbiol. 2017 Jan;19(1):29-41
pubmed: 27928878
J Med Biol Eng. 2016;36(5):605-624
pubmed: 27853412
Clin Cancer Res. 2019 Jul 1;25(13):3753-3758
pubmed: 30787022
Animal. 2021 Dec;15(12):100413
pubmed: 34844190
PLoS One. 2012;7(9):e45371
pubmed: 23028967
Metabolites. 2019 Sep 21;9(10):
pubmed: 31546636
J Oral Microbiol. 2021 Jun 16;13(1):1886748
pubmed: 34188775
Arthritis Care Res (Hoboken). 2010 Nov;62(11):1633-8
pubmed: 20617533
J Periodontal Res. 2014 Oct;49(5):574-83
pubmed: 25340203
Subst Use Misuse. 2022;57(10):1545-1551
pubmed: 35861665
J Clin Exp Dent. 2015 Oct 01;7(4):e501-5
pubmed: 26535097
J Dent Res. 2002 Jun;81(6):422-7
pubmed: 12097436
J Periodontal Res. 2018 Oct;53(5):894-901
pubmed: 29974463
Lab Chip. 2022 Jun 28;22(13):2451-2475
pubmed: 35713489
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
PLoS One. 2014 Aug 18;9(8):e105181
pubmed: 25133529
Odontol Revy Suppl. 1974;32:1-143
pubmed: 4614155
Gen Dent. 2017 Nov-Dec;65(6):30-34
pubmed: 29099363
Mol Biosyst. 2013 Jan 27;9(1):18-28
pubmed: 23114495
Arthritis Rheumatol. 2015 Apr;67(4):1084-95
pubmed: 25545990
J Oral Biol Craniofac Res. 2016 Jan-Apr;6(1):66-75
pubmed: 26937373
Appl Environ Microbiol. 2014 Jul;80(14):4108-13
pubmed: 24795365
Biofactors. 2006;27(1-4):121-36
pubmed: 17012769
Anal Chem. 2019 Sep 3;91(17):11063-11069
pubmed: 31397558
J Thorac Oncol. 2021 Apr;16(4):537-545
pubmed: 33545385
Metabolomics. 2020 Aug 25;16(9):90
pubmed: 32840693
J Periodontal Res. 2016 Aug;51(4):431-7
pubmed: 26446036